4/A//SEC Filing
Zauderer Maurice 4/A
Accession 0001062993-24-010185
CIK 0001205922other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:34 PM ET
Size
6.1 KB
Accession
0001062993-24-010185
Insider Transaction Report
Form 4/AAmended
VACCINEX, INC.VCNX
Zauderer Maurice
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-03-21+1,877→ 1,877 totalExercise: $8.21Exp: 2034-03-21→ Common Stock (1,877 underlying)
Footnotes (3)
- [F1]Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $9.15 that was listed in the original Form 4.
- [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date.
- [F3]Due to an administrative error, the original Form 4 mistakenly listed the stock option expiration date as March 20, 2029. The expiration date is actually March 21, 2034.
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747753
Filing Metadata
- Form type
- 4/A
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:34 PM ET
- Size
- 6.1 KB